NCT02974530

Brief Summary

The oropharyngeal junction participates in 3 interpenetrating functions: Swallowing, Breathing and Speech. In the context of ischemic or hemorrhagic stroke, these are altered, isolated or associated manner, causing major disorders and representing a source of handicap for patients. Understanding the swallowing mechanisms is therefore a major challenge to guide the rehabilitation and improve the initial and long-term prognosis of patients with stroke. The main objective of this study is to describe and modeling, thanks to a clinical, physiological and radiological knowledge base, swallowing, speech and breathing, in patients with stroke and in healthy subjects.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2016

Typical duration for all trials

Geographic Reach
1 country

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 1, 2016

Completed
3 months until next milestone

First Posted

Study publicly available on registry

November 28, 2016

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2019

Completed
Last Updated

July 17, 2017

Status Verified

August 1, 2016

Enrollment Period

2 years

First QC Date

September 1, 2016

Last Update Submit

July 12, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change of Clinical severity score

    NIHSS scale

    At inclusion and 6 months after diagnosis

  • Change of swallowing disorder

    Test : GUgging Swallowing Screen

    Within 15 days after diagnosis and 6 months after diagnosis

Secondary Outcomes (3)

  • Change of aphasia disorder

    Within 15 days after diagnosis and 6 months after diagnosis

  • Change of state of depression and anxiety

    Within 15 days after diagnosis and 6 months after diagnosis

  • Change of behavioural attention

    Within 15 days after diagnosis and 6 months after diagnosis

Study Arms (2)

Stroke population

Patient with stroke will be explored during their acute phase and in 6 months of diagnosis.

Other: Neurological evaluationOther: Laryngological evaluationOther: MRI evaluationOther: Breathing investigationOther: Postural investigationOther: Voice and soundscape investigation

Healthy population

Healthy subjects will be explored in Grenoble in research laboratory

Other: Breathing investigationOther: MRI and articulatory investigationOther: Postural investigationOther: Voice and soundscape investigation

Interventions

Stroke population
Stroke population
Stroke population
Healthy populationStroke population
Healthy population
Healthy populationStroke population
Healthy populationStroke population

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Multicenter study with two cohorts unpaired : first of healthy subjects / second of patient with ischemic stroke. Study size expected : * 120 stroke patients in 4 University Hospital * 30 healthy subjects explored in research laboratory

You may qualify if:

  • First stroke confirmed by MRI \< 15 days
  • No severe leukoaraiosis
  • Swallowing disorders identified (GUSS scale \< 20)
  • Neurological deficit identified (NIHSS scale \<15)
  • Patient able to cooperate for investigations
  • Informed consent signed

You may not qualify if:

  • Cerebral hemorrhage
  • History of neurological disease that can lead to swallowing disorders
  • History of laryngological disease such as previous surgery or radiation neck
  • Tracheotomy
  • Vigilance disorders
  • Pregnant, parturient or nursing woman
  • Protected adult
  • Simultaneous participation in another study
  • Non registered to the French social security system
  • For healthy subjects
  • Age between 18 and 40 years old
  • French native speaker
  • Normal hearing with or without corrective
  • No oral or written language disorders
  • No neurological or psychiatric disorders
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Hospital

Aix-en-Provence, France

NOT YET RECRUITING

University hospital

Caen, France

RECRUITING

University hospital

Grenoble, France

RECRUITING

University hospital

Montpellier, France

NOT YET RECRUITING

MeSH Terms

Conditions

StrokeDeglutition Disorders

Interventions

Magnetic Resonance SpectroscopyVoice

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative TechniquesRespiratory Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Central Study Contacts

Marc Hommel, MD

CONTACT

Philippe Cousin

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2016

First Posted

November 28, 2016

Study Start

August 1, 2016

Primary Completion

August 1, 2018

Study Completion

February 1, 2019

Last Updated

July 17, 2017

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share

Locations